The eligibility criteria for the studies were established based on
the PICOS framework, which considers population, intervention, comparison, outcome, and
study design (Table 2). This review included randomized clinical trials
involving adult women (aged 18 years or older) who were
undergoing or had completed treatment for breast cancer.